8-K: Current report filing
Published on January 9, 2006
U.S.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934.
Date
of Report: January 6, 2006
Commission
File Number: 000-51578
CryoPort,
Inc.
(Exact
name of small business issuer as specified in its charter)
Nevada
|
88-0313393
|
||
(State
or other jurisdiction of
incorporation
or organization)
|
(IRS
Employer
Identification
No.)
|
||
451
Atlas Street Brea, California, 92821
|
|||
(Address
of principal executive offices)
|
|||
Tel:
(714) 256-6100 Fax: (714) 256-6110
|
|||
(Issuer’s
telephone number and fax number)
|
|||
Not
Applicable
|
|||
(Former
name, former address and former fiscal year, if changed since last
report)
|
|||
Item
5.
Other Events.
At
a
Board of Directors (the Board) meeting held on December 15, 2005, the Board
unanimously voted to expand the number of members of the Board from five to
seven as allowed by the Company Bylaws. The Board then appointed two additional
independent directors, Thomas S. Fischer, PhD and Stephen L. Scott, to fill
these vacant positions.
The
additions to the Board were made to insure further compliance with the
Sarbanes-Oxley Act and to meet requirements to be listed on the NASDAQ Capital
Markets Exchange.
Thomas
S.
Fischer, PhD, has over 20-years experience as a healthcare executive with a
special emphasis on using information, analytic tools and technology to solve
problems and improve operations. Currently retired, he consults in the
healthcare sector. Dr. Fischer previously served as Senior Vice President and
Chief Administrative Officer at Blue Shield of California from 1997 to 1999,
and
as Senior Vice President, Chief Information Officer from 1994 to 1997. Prior
to
Blue Shield, he held senior management positions with Kaiser Foundation Health
Plan, Inc. for 12 years. Dr. Fischer obtained his Doctor of Philosophy in
Mathematics from the University of Nebraska and his Bachelor of Science and
Master of Science degrees from Portland State University.
Stephen
L. Scott is a management and organizational consultant with over 20-years
experience with diverse manufacturing businesses, including a specific
background with developmental stage companies. Since 1996, Mr. Scott has been
President of Technology Acquisition Group, providing expertise in corporate
growth planning, strategic partner development, finance, operations, team
building, product opportunity identification, corporate re-engineering and
mergers and acquisitions. In addition to early stage and small companies, he
has
performed projects with Fortune 1000 firms such as IBM, GE, AT&T,
Bristol-Myers Squibb, Warner-Lambert, Johnson & Johnson and Ayerst-Wyeth.
Mr. Scott received his Juris Doctorate and Masters of Business Administration
degrees from National University and his Bachelor of Science degree from the
University of Akron.
On
December 16, 2005, CryoPort, Inc. filed its application to be listed on the
NASDAQ Capital Markets Exchange. The Company expects approval to be listed
upon
the NASDAQ Capital Markets Exchange once the SEC has completed its comment
process on the Company’s Form 10-SB filing.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the Undersigned hereunto
duly authorized.
CryoPort, Inc. | ||
|
|
|
Date: January 6, 2005 | By: | /s/ Peter Berry, |
Chief Executive Officer, President |
||